MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 301 to 320 of 5,858 approvalsPage 16 of 293

LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03%

Approval Number: SIN16938P
Approval: Jan 30, 2024

A-TADALAFIL FILM-COATED TABLETS 10 MG

Approval Number: SIN16935P
Approval: Jan 26, 2024

A-TADALAFIL FILM-COATED TABLETS 5 MG

Approval Number: SIN16936P
Approval: Jan 26, 2024

A-TADALAFIL FILM-COATED TABLETS 20 MG

Approval Number: SIN16934P
Approval: Jan 26, 2024

A-TADALAFIL FILM-COATED TABLETS 2.5 MG

Approval Number: SIN16937P
Approval: Jan 26, 2024

SUGAMMADEX SCIGEN SOLUTION FOR INJECTION 100MG/ML

Approval Number: SIN16933P
Approval: Jan 23, 2024

DIFFORAL CAPSULES 125MG

Approval Number: SIN16931P
Approval: Jan 17, 2024

DIFFORAL CAPSULES 250MG

Approval Number: SIN16932P
Approval: Jan 17, 2024

COGNIMET FILM-COATED TABLET 10MG

Approval Number: SIN16928P
Approval: Jan 16, 2024

LEVETIRACETAM VIATRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/ML

Approval Number: SIN16930P
Approval: Jan 16, 2024
mylan pharmaceuticals pte. ltd.

GENCEBOK SOLUTION FOR INFUSION 10MG/ML

Approval Number: SIN16929P
Approval: Jan 16, 2024

LATACOM EYE DROPS

Approval Number: SIN16927P
Approval: Jan 12, 2024

FUNGIFEX TABLET 250MG

Approval Number: SIN16925P
Approval: Jan 5, 2024

URSOSAN HARD CAPSULES 250 MG

Approval Number: SIN16926P
Approval: Jan 5, 2024

GLILUPI MR TABLET 60MG

Approval Number: SIN16924P
Approval: Dec 29, 2023

LIPOCOMB HARD CAPSULE 10MG/10MG

Approval Number: SIN16920P
Approval: Dec 21, 2023

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.